|
1
|
Miller AJ and Mihm MC Jr: Melanoma. N Engl
J Med. 355:51–65. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brose MS, Volpe P, Feldman M, Kumar M,
Rishi I, Gerrero R, Einhorn E, Herlyn M, Minna J, Nicholson A, et
al: BRAF and RAS mutations in human lung cancer and melanoma.
Cancer Res. 62:6997–7000. 2002.PubMed/NCBI
|
|
3
|
Haass NK, Smalley KS, Li L and Herlyn M:
Adhesion, migration and communication in melanocytes and melanoma.
Pigment Cell Res. 18:150–159. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baroudjian B, Pagès C and Lebbè C:
Melanoma, from diagnosis to treatment. Rev Infirm. 16–18. 2016.(In
French). View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Barth A, Wanek LA and Morton DL:
Prognostic factors in 1,521 melanoma patients with distant
metastases. J Am Coll Surg. 181:193–201. 1995.PubMed/NCBI
|
|
6
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ebert MS and Sharp PA: MicroRNA sponges:
Progress and possibilities. RNA. 16:2043–2050. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fang W, Fan Y, Fa Z, Xu J, Yu H, Li P and
Gu J: microRNA-625 inhibits tumorigenicity by suppressing
proliferation, migration and invasion in malignant melanoma.
Oncotarget. 8:13253–13263. 2017.PubMed/NCBI
|
|
12
|
Brueckner B, Stresemann C, Kuner R, Mund
C, Musch T, Meister M, Sultmann H and Lyko F: The human let-7a-3
locus contains an epigenetically regulated microRNA gene with
oncogenic function. Cancer Res. 67:1419–1423. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Miyaki M and Kuroki T: Role of Smad4
(DPC4) inactivation in human cancer. Biochem Biophys Res Commun.
306:799–804. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang G and Yang X: Smad4-mediated TGF-beta
signaling in tumorigenesis. Int J Biol Sci. 6:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng Y, Zhu J, Shen D, Qin H, Lei Z, Li W,
Liu Z and Huang JA: MicroRNA-205 targets SMAD4 in non-small cell
lung cancer and promotes lung cancer cell growth in vitro and in
vivo. Oncotarget. 8:30817–30829. 2016.
|
|
17
|
Yan P, Klingbiel D, Saridaki Z, Ceppa P,
Curto M, McKee TA, Roth A, Tejpar S, Delorenzi M, Bosman FT and
Fiocca R: Reduced expression of SMAD4 is associated with poor
survival in colon cancer. Clin Cancer Res. 22:3037–3047. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang LH, Kim SH, Lee JH, Choi YL, Kim YC,
Park TS, Hong YC, Wu CF and Shin YK: Inactivation of SMAD4 tumor
suppressor gene during gastric carcinoma progression. Clin Cancer
Res. 13:102–110. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stuelten CH, Buck MB, Dippon J, Roberts
AB, Fritz P and Knabbe C: Smad4-expression is decreased in breast
cancer tissues: A retrospective study. BMC Cancer. 6:252006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ding Z, Wu CJ, Chu GC, Xiao Y, Ho D, Zhang
J, Perry SR, Labrot ES, Wu X, Lis R, et al: SMAD4-dependent barrier
constrains prostate cancer growth and metastatic progression.
Nature. 470:269–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Meng X, Zhao Y, Wang J, Gao Z, Geng Q and
Liu X: Regulatory roles of miRNA-758 and matrix extracellular
phosphoglycoprotein in cervical cancer. Exp Ther Med. 14:2789–2794.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei YT, Guo DW, Hou XZ and Jiang DQ:
miRNA-223 suppresses FOXO1 and functions as a potential tumor
marker in breast cancer. Cell Mol Biol (Noisy-le-grand).
63:113–118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zu Y, Yang Y, Zhu J, Bo X, Hou S, Zhang B,
Qiu J and Zheng J: miR-146a suppresses hepatocellular carcinoma by
downregulating TRAF6. Am J Cancer Res. 6:2502–2513. 2016.PubMed/NCBI
|
|
25
|
Liu Q, Wang W, Yang X, Zhao D, Li F and
Wang H: MicroRNA-146a inhibits cell migration and invasion by
targeting RhoA in breast cancer. Oncol Rep. 36:189–196. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu D, Yao Q, Zhan C, Le-Meng Z, Liu H, Cai
Y, Tu C, Li X, Zou Y and Zhang S: MicroRNA-146a promote cell
migration and invasion in human colorectal cancer via
carboxypeptidase M/src-FAK pathway. Oncotarget. 8:22674–22684.
2017.PubMed/NCBI
|
|
27
|
Hung PS, Liu CJ, Chou CS, Kao SY, Yang CC,
Chang KW, Chiu TH and Lin SC: miR-146a enhances the oncogenicity of
oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and
NUMB genes. PLoS One. 8:e799262013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X, Cao J, Pei Y, Zhang J and Wang Q:
Smad4 inhibits cell migration via suppression of JNK activity in
human pancreatic carcinoma PANC-1 cells. Oncol Lett. 11:3465–3470.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiao B, Zhu ED, Li N, Lu DS, Li W, Li BS,
Zhao YL, Mao XH, Guo G, Yu PW and Zou QM: Increased miR-146a in
gastric cancer directly targets SMAD4 and is involved in modulating
cell proliferation and apoptosis. Oncol Rep. 27:559–566.
2012.PubMed/NCBI
|
